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Strand- and site-specific DNA lesion demarcation by the
xeroderma pigmentosum group D helicase
Abstract
The most detrimental responses of the UV-exposed skin are triggered by cyclobutane pyrimidine dimers
(CPDs). Although placental mammals rely solely on nucleotide excision repair (NER) to eliminate
CPDs, none of the core NER factors are apparently able to distinguish this hazardous lesion from native
DNA, raising the question of how CPDs are circumscribed to define correct excision boundaries. A key
NER intermediate involves unwinding of the damaged duplex by transcription factor TFIIH, a reaction
that requires xeroderma pigmentosum group D (XPD) protein. This study was prompted by the
observation that the ATPase/helicase activity of XPD is necessary for an effective anchoring of this
subunit to UV lesions in mammalian nuclei. The underlying mechanism by which XPD impinges on
damaged DNA has been probed with a monomeric archaeal homolog, thus revealing that the collision
with a single CPD inhibits the helicase but stimulates its ATPase activity. Restriction and glycosylase
protection assays show that the XPD helicase remains firmly bound to a CPD situated in the translocated
strand along which the enzyme moves with 5'-3' polarity. Competition assays confirm that a stable
complex is formed when the XPD helicase encounters a CPD in the translocated strand. Instead, the
enzyme dissociates from the substrate after running into a CPD in the complementary 3'-5' strand. These
results disclose a damage verification and demarcation process that takes place by strand-selective
immobilization of the XPD helicase and its conversion to a site-specific ATPase at DNA lesions.
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The most detrimental responses of the UV-exposed skin are triggered by cyclobutane 
pyrimidine dimers (CPDs). Although placental mammals rely solely on nucleotide 
excision repair (NER) to eliminate CPDs, none of the core NER factors is apparently 
able to distinguish this hazardous lesion from native DNA, raising the question of how 
CPDs are circumscribed to define correct excision boundaries. A key NER intermediate 
involves unwinding of the damaged duplex by transcription factor TFIIH, a reaction 
that requires xeroderma pigmentosum group D (XPD) protein. This study was 
prompted by the observation that the ATPase/helicase activity of XPD is necessary for 
an effective anchoring of this subunit to UV lesions in mammalian nuclei. The 
underlying mechanism by which XPD impinges on damaged DNA has been probed with 
a monomeric archaeal homolog, thus revealing that the collision with a single CPD 
inhibits the helicase but stimulates its ATPase activity. Restriction and glycosylase 
protection assays show that the XPD helicase remains firmly bound to a CPD situated 
in the translocated strand along which the enzyme moves with 5’–3’ polarity. 
Competition assays confirm that a stable complex is formed when the XPD helicase 
encounters a CPD in the translocated strand. Instead, the enzyme dissociates from the 
substrate after running into a CPD in the complementary 3’–5’ strand. These results 
disclose a damage verification and demarcation process that takes place by strand-
selective immobilization of the XPD helicase and its conversion to a site-specific ATPase 
at DNA lesions. 
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\body 
The absorption of UV light by DNA results in mutagenic crosslinks between adjacent bases, 
primarily cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) photoproducts (6-
4PPs) (1, 2). Of these photolesions, CPDs are responsible for a majority of the severe 
endpoints of UV radiation such as cutaneous erythema, hyperplasia and cancer (3, 4). The 
adverse UV effects are alleviated by a plethora of DNA damage responses, but nucleotide 
excision repair (NER) represents the only error-free mechanism for photodimer removal in 
placental mammals (5-7). The relevance of DNA repair is highlighted by the inherited 
disorder xeroderma pigmentosum (XP) where defects in global-genome NER, operating 
across the entire genome, lead to a > 1000-fold increased incidence of sunlight-induced skin 
cancer (8, 9). This genome-wide pathway is initiated by the XPC-Rad23B complex, which 
acts as a generic sensor of DNA distortions (10, 11). The XPC subunit provides a landing 
platform for transcription factor TFIIH, whose unwinding activity assisted by XPA and 
replication protein A (RPA) generates a NER intermediate in which the DNA is melted over 
25-30 nucleotides. Finally, the margins of this open complex are cleaved by structure-specific 
endonucleases that release the offending damage by dual DNA incision (12, 13). 
The problem of detecting CPDs, as opposed to 6-4PPs, resides with the minimal 
thermodynamic and structural changes caused by this type of lesion (14, 15). Although the 
core NER subunits implicated in damage recognition (XPC-Rad23B, XPA and RPA) all 
display an increased affinity for 6-4PPs, they fail to discriminate between CPD sites and the 
native double helix (16-18). As an alternative means of detecting NER substrates, vertebrate 
organisms display an auxiliary factor known as UV-damaged DNA-binding (UV-DDB) 
protein (19, 20). This extra player provides a DNA-binding subunit (DDB2) that detects the 
otherwise poorly recognizable CPDs but is itself not a component of the ultimate recognition 
complex. In fact, upon XPC recruitment, UV-DDB leaves the CPD site (21) and DDB2 is 
degraded (22). Also, UV-DDB binds with high affinity to mismatched bases and abasic sites, 
which are not or only poorly processed by the mammalian NER system (23). Thus, the key 
question is how downstream factors verify damaged sites and distinguish CPDs, or other 
similar lesions that resemble undamaged DNA, from the native double helix. 
 To form open intermediates, the TFIIH complex uses two unwinding enzymes that differ 
in their catalytic properties. XPD represents the dominant helicase with 5’–3’ polarity (24) 
whose enzymatic function is required for DNA repair but not for transcription (25, 26). 
Instead, XPB is an ATPase with minor 3’–5’ helicase activity (26). Recent biochemical and 
structural studies demonstrated that archaeal homologs provide an excellent model to analyze 
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the specialized role of the XPD subunit in the NER pathway (27). Therefore, we used the 
XPD protein of a mesophilic archaeon to monitor the consequences of a collision of this 
DNA helicase with CPD lesions. Together with the shortened residence time of an active site 
mutant in nuclear UV foci, our molecular analysis reveals that the XPD helicase acts as a 
dynamic sensor that scans DNA and thereby promotes a strand-selective lesion verification 
process, which culminates in site-specific lesion demarcation. 
 
Results 
Anchoring to foci of DNA damage. To test the interaction of human XPD with damaged 
DNA in living cells, we exploited the fact that a catalytically inactive mutant carrying a 
K48R substitution in its ATPase motif is readily incorporated into the TFIIH complexes of 
Chinese hamster ovary (CHO) cells (25). The ATPase/DNA helicase activity of XPD is not 
essential for the actual recruitment of TFIIH to damaged sites (28). Therefore, wild-type and 
mutant XPD were fused with green-fluorescent protein (GFP) to visualize their accumulation 
in UV-irradiated nuclear areas. Foci of UV damage were identified by immunostaining and, 
as observed before (28), both fusion proteins showed a faithful co-localization with CPD 
spots, demonstrating that TFIIH assembled with inactive XPD is engaged at damaged sites 
(Fig. 1A). However, by quantifying the signals in cells expressing equal levels of fusion 
proteins, we found that the K48R mutant yields foci with lower fluorescence intensity than 
the wild-type control (Fig. 1B). 
The cause of this intriguing difference between active and inactive polypeptides was 
examined by subjecting the XPD-GFP foci to analyses by fluorescence recovery after 
photobleaching on local damage (FRAP-LD). For that purpose, the fluorescence of individual 
foci was photobleached to reduce their intensity to the same level as the nuclear background. 
Subsequently, fluorescence redistributions due to the exchange of bleached molecules with 
non-bleached counterparts (29) were recorded over time, thus yielding distinct residence 
times (Fig. 1C). The diverging plateau of the fluorescence recovery profiles reveals that the 
wild-type enzyme persists in the UV foci whereas the K48R mutant dissociates completely 
from lesion sites. Thus, the distinguishable dissociation curves indicate that the intrinsic 
ATPase/helicase activity of XPD protein results in the immobilization of this central TFIIH 
subunit onto damaged DNA. 
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Binding of XPD helicase to a site-directed CPD. Next, an archaeal homolog closely related 
in sequence to the human enzyme and active at moderate temperatures (30) was used to test 
how the XPD subunit interacts with native and damaged substrates. This XPD protein from 
Ferroplasma acidarmanus (FaXPD) was purified (Fig. 2A) and incubated with radiolabeled 
51-mer oligonucleotides (Fig. 2B). When the nucleoprotein products were monitored in 
electrophoretic mobility shift assays, a nearly complete association with single-stranded DNA 
was detected after 15-min preincubations in the presence of ATP, regardless of whether the 
oligonucleotides were undamaged (Fig. 2C; lane 2) or modified with a site-directed CPD 
(lane 9). 
The complexes were then challenged by the addition of a 50-fold molar excess of 
unlabeled 51-mers. If the substrate is undamaged, ATP hydrolysis drives an unhindered XPD 
movement towards the 3’-terminal nucleotides, where the enzyme dissociates from the DNA 
ends. Subsequent re-associations take place preferentially with the surplus of unlabeled DNA, 
resulting in a progressive loss of radiolabeled complexes as demonstrated in Fig. 2C (lanes 3-
8). After a 30-min incubation with competitor DNA, the radiolabeled probes were completely 
released from their interaction with the protein and migrated into the gel as free 
oligonucleotides (Fig. 2C, compare lanes 1 & 8). Fig. 2D shows that this dissociation from 
undamaged oligonucleotides does not take place in the absence of ATP (lane 3) or upon the 
replacement of ATP with a non-hydrolyzable analog (lane 4). On the other hand, when the 
labeled oligomers carry a CPD, the XPD helicase forms nucleoprotein complexes that are 
refractory to the challenge with contending DNA (Fig. 2C, lanes 10-15; Fig. 2D, lane 6). The 
quantification of these competition assays demonstrates that the enzyme remains tightly 
bound to CPD-modified oligonucleotides, whereas, in the absence of damage, the complexes 
gradually dissociate until all radiolabeled oligomers are released (Fig. 2E). These findings 
indicate that the active XPD helicase discriminates CPDs by generating a stable intermediate 
after encountering the lesion during its 5’-3’ movement along single-stranded DNA. 
 
Inhibition of DNA helicase activity. To examine the consequences of a dynamic collision 
with damaged bases during the unwinding of double-stranded DNA, partial duplex substrates 
were constructed with a single CPD either in the 5’–3’ translocated or the 3’–5’ displaced 
strand (Fig. 3A & Fig. S1). In these substrates, single-stranded overhangs of 44 nucleotides 
are flanked by a duplex segment of 81 base pairs designed to contain the CPD lesion within a 
unique EcoRI sequence. Accordingly, the modification could be confirmed by EcoRI 
restriction, which is suppressed by a CPD in one of the two DNA strands (Fig. S2). 
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We established by mobility shift assays that the CPD does not impede the initial 
association of FaXPD with forked DNA molecules. A saturating substrate binding is 
observed at an XPD concentration of 75 nM regardless of whether or not the partial duplexes 
carry a CPD lesion (Fig. S3). However, the presence of a single CPD in the translocated 5’–
3’ strand led to a pronounced inhibition of DNA helicase activity and a more moderate 
inhibition was detected when the CPD was located in the displaced 3’–5’ strand (Fig. 3B). 
Dose dependence (Fig. 3C) and time course experiments (Fig. 3D) confirmed that, at all 
tested protein concentrations and incubation periods, damaged substrates containing a CPD 
result in less efficient helicase activity compared to the undamaged control. Thus, CPDs 
represent a barrier to the movement of the XPD helicase along DNA. 
 
Stimulation of ATPase activity. The kinetics of ATP hydrolysis was tested in helicase 
reaction mixtures containing 45-75 nM of FaXPD and 5 nM forked DNA. The ability of the 
XPD enzyme to hydrolyze ATP is dependent on the presence of DNA but, surprisingly, the 
observed suppression of helicase activity was not paralleled by a corresponding inhibition of 
the ATPase reaction. On the contrary, the forked DNA substrate containing a CPD in the 5’–
3’ translocated strand induces higher levels of ATP hydrolysis than the undamaged control or 
the counterpart with a CPD in the 3’–5’ displaced strand (Fig. 3E). Time course experiments 
confirmed that a CPD in the 5’–3’ strand results in increased rates of ATP hydrolysis 
compared to duplexes where either the 5’–3’ strand or both strands are undamaged (Fig. 3F). 
It may be argued that 125-mer substrates with just one lesion still contain sufficient native 
DNA to stimulate ATPase activity at positions flanking the CPD. Therefore, ATPase assays 
were carried out with oligonucleotides of 30 or 51 residues in length. Overall, these short 
oligomers induce less ATP hydrolysis than forked substrates but the ones carrying a CPD 
were again slightly more effective than the undamaged controls (Fig. S4). Thus, even very 
short CPD-damaged oligonucleotides promote ATPase activity despite the fact that the 
helicase is blocked at the lesion sites. These findings indicate that DNA damage inhibits the 
XPD helicase function but not the accompanying ATPase activity. 
 
Protection from restriction digestion. After running into a CPD during DNA unwinding, 
the helicase may either dissociate from the duplex or, alternatively, form a tight complex as 
observed in Fig. 1 with single-stranded DNA. To analyze the fate of FaXPD encountering a 
lesion, the CPD modification in forked substrates was flanked by restriction sites for HaeIII 
(upstream of the CPD; Fig. 4A), SalI (in close vicinity to the CPD) and PstI (downstream of 
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the CPD). These endonucleases were used to probe the products of 15-min helicase reactions. 
Efficient cleavage would show that the respective restriction sequence is protein-free whereas 
reduced cutting would indicate a close interaction of the XPD helicase thereby shielding the 
DNA substrate from digestion. 
When the preceding helicase reaction was performed with a CPD in the 5’–3’ 
translocated strand, the SalI cleavage was completely inhibited (Fig. 4B; lanes 2-5). This SalI 
site is occluded only when the preincubation mixture is supplied with all helicase reagents. 
No protection was detected when either the XPD enzyme itself or one of the cofactors (ATP 
or MgCl2) was omitted during the preincubation (Fig. 4B; lanes 6-9). These results confirm 
that the 5’–3’ movement of the XPD helicase is arrested by a CPD lesion, resulting in a stable 
nucleoprotein complex at damaged sites. Instead, the XPD helicase fails to protect from SalI 
cleavage if the CPD is located in the 3’–5’ displaced strand (Fig. 4B; lanes 11-14), indicating 
that the collision with a lesion in the opposing strand triggers dissociation of the enzyme from 
DNA. 
Contrary to the findings with SalI, the helicase was unable to prevent the digestion by 
HaeIII (Fig. S5A), indicating that the respective site located 16 nucleotides upstream of the 
CPD remains free of protein even though the adjacent SalI region is obstructed by a stalled 
XPD. Similarly, preincubation with XPD did not protect from the cleavage by PstI, whose 
restriction site is located 15 nucleotides downstream of the lesion (Fig. S5B). In summary, 
these endonuclease protection assays indicate that, by forming stable nucleoprotein 
interactions precisely at the damaged position, the XPD helicase demarcates CPD lesions in a 
strand-selective and site-specific manner. 
 
Protection from glycosylase digestion. Single-stranded or forked substrates were 
preincubated for 15 min with XPD and the reaction products were challenged by T4 denV, a 
DNA glycosylase that catalyzes the incision of CPD sites in both single- and double-stranded 
DNA (31). With the CPD-modified 51-mer oligonucleotide, the activity of T4 denV 
generates a radiolabeled fragment of 27 residues (Fig. 4C; lane 2). However, this CPD-
specific cleavage was prevented when damaged substrates were preincubated with FaXPD in 
the presence of ATP and MgCl2 (lane 3). In control reactions, cleavage by T4 denV, 
producing the 27-mer fragment, was restored when either the helicase, ATP or MgCl2 was 
omitted from the preincubation mixture (Fig. 4C; lanes 4-7). 
When the same protection assay is applied to forked substrates with a CPD in the 
translocated 5’–3’ strand, cleavage by T4 denV yields a radiolabeled fragment of 101 
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residues (Fig. 4C; lane 10). This CPD-specific cleavage was suppressed after a 15-min 
preincubation with the complete helicase mixture (lane 11). Instead, no inhibition of T4 denV 
cleavage occurred when either the XPD helicase, ATP or MgCl2 was missing during the 
preincubation period (Fig. 4C, lanes 12-15). Also, no inhibition of denV cleavage was 
detected when XPD was incubated with forked substrates containing a CPD in the opposing 
displaced strand (Fig. S6). These glycosylase protection assays show that the XPD helicase 
makes very close contacts with DNA lesions that obstruct its 5’–3’ movement. 
 
Discussion 
This report bears on the discovery that global-genome NER is initiated by a versatile sensor 
that detects the single-stranded character of unpaired bases rather than the target lesions 
themselves (10, 11). The XPC-Rad23B initiator, like its UV-DDB partner, even binds to 
mismatched bases that, in the absence of chemical modifications, fail to induce NER activity 
(18, 23). Such a lesion-independent action implies that the NER pathway must include a 
follow-up step to verify the presence of base modifications (18, 32). While the nature of this 
verification process remained poorly defined, a previous reconstitution assay suggested that 
the loading of XPC onto DNA results in a NER intermediate that searches for base damage in 
the 5’–3’ direction (33). One key finding of the present study is that the enzymatic activity of 
XPD promotes its own anchoring to damaged DNA in living cells, thus supporting the 
conclusion that XPD is directly responsible for the predicted lesion verification step. 
Earlier studies on the Rad3 protein of S. cerevisiae indicated that the helicase activity of 
this yeast XPD homolog is suppressed after substrate treatment with various DNA-damaging 
agents (34). Although archaeal XPD homologs provide an excellent model to study the 
function of this evolutionary conserved protein (34-36), recently, Rudolf et al. (38) reported 
that damaged bases do not inhibit the DNA unwinding by such an archaeal enzyme. Our 
present study was focused on CPDs as an example of abundant and highly mutagenic lesions 
for which an effective verification process appears critical because they evade recognition by 
the core damage sensors including XPC-Rad23B (6, 18). It is important to note that UV-
DDB, which is required for CPD recognition in the global-genome pathway, is displaced 
from the repair target after recruitment of XPC-Rad23B (21). Similarly, in transcribed 
sequences, DNA damage is detected by RNA polymerase II, which is released from repair 
sites before excision can occur (39, 40). Thus, in both subpathways at least one additional 
player must take over a lesion verification function in order to demarcate CPDs and define 
the correct positions as well as orientation of DNA cleavage. Being a component of the 
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TFIIH complex (24-28), XPD is strategically placed at the crossroad between global-genome 
and transcription-coupled repair (12, 13). 
Here, the interplay between the XPD helicase and DNA lesions has first been examined 
in competition assays that challenge the stability of nucleoprotein complexes formed when 
this enzyme collides with a single CPD. Second, the effect of CPDs on DNA helicase activity 
was tested across a wide range of enzyme concentrations using substrates with a long 81-mer 
duplex region. Third, we determined how CPDs influence the rate of DNA-dependent ATP 
hydrolysis. Finally, the unwinding junctions were probed by digestion with endonucleases 
and a CPD-specific glycosylase. In combination, our findings demonstrate that XPD forms a 
tight complex with the DNA substrate after encountering a lesion during its directional 
5’→3’ movement, thus providing a dynamic mechanism for strand-selective and site-specific 
lesion demarcation in the NER pathway. Our current data do not contradict the previously 
mentioned experiments by Rudolf et al. (38), who concluded that there is no inhibition of 
DNA unwinding by a CPD located in a 19-base pair segment. Indeed, if the XPD enzyme 
senses the lesion and remains in place at the damaged site, as demonstrated in our study, it 
would still destabilize the short DNA duplex of that earlier report to a sufficient degree to 
cause strand separation. 
As observed for UvrB, the ultimate recognition subunit in the prokaryotic NER system 
(41), the ATPase activity of XPD is stimulated by CPDs. Thus, the enzyme is not 
“paralyzed”, but retains the ability to hydrolyze ATP when encountering damaged sites. We 
propose a model whereby the XPD helicase is arrested by lesions situated in the translocated 
DNA strand and, thereafter, changes its catalytic properties to cooperate with the XPB 
partner (26, 28) as a site-specific ATPase. The combined action of these two unwinding 
enzymes generates the local bubble transition necessary for dual incision. An attractive 
feature of this model is that a stable nucleoprotein intermediate that allows for DNA incision 
can only be formed by damage-induced immobilization of the XPD subunit, such that its 
activity is focused on the lesion site without further translocation of the TFIIH complex. 
Instead, native DNA regions that fail to inhibit the XPD helicase are bypassed and will not be 
presented as a substrate to the NER system. This inherent verification mechanism serves as a 
decision point in the NER pathway to ensure that DNA incision only takes place at sites of 
true base damage. 
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Materials and Methods 
Analysis of nuclear XPD foci. Local areas of DNA damage were generated in CHO nuclei 
by UV irradiation (150 J/m2) through polycarbonate filters. Fluorescent protein accumulation 
and protein dynamics at lesion sites were monitored as described in SI Text. 
 
Enzymes. The F. acidarmanus XPD was expressed with an N-terminal His6-tag in E. coli 
(BL21-Codon Plus, Stratagene) using a pET28a vector kindly provided by Dr. M. Spies 
(University of Illinois, Urbana IL, USA). The helicase was purified by affinity (HisTrap HP 
and HiTrap Heparin columns, GE Healthcare) and anion exchange chromatography (HiTrap 
Q XL) as described (30). Restriction enzymes were from New England Biolabs and T4 denV 
was from Epicentre. 
 
Oligonucleotides. The CPD building block was purchased from GlenResearch. The 
oligomers 5’-GCCTGCAGTCAGCGTCGACTCGAATTCCCG-3’ and 5’-
CATGATTACGGCCATATCGAGCGGGAATTCGAGTCGACGCTGACTGCAGGC-3’, 
with a CPD at the position of the underlined thymines, were provided by Trilink 
Biotechnologies. 
 
DNA-binding assays. The indicated concentrations of FaXPD were incubated (25°C, 15 
min) with radiolabeled substrates (5 nM), either forked duplexes (without ATP) or 51-mer 
oligonucleotides (in the presence of 3 mM ATP). The buffer (15 µl) consisted of 20 mM 
Tris-HCl (pH 7.5), 5 mM MgCl2 and 2 mM dithiothreitol (DTT). Competition was started by 
adding 250 nM unlabeled 51-mers. After different incubation periods, the samples were 
transferred on ice, supplemented with 5 µl loading buffer [100 mM Tris-HCl (pH 8.3), 10% 
(v/v) glycerol and 0.05% (w/v) orange G] and resolved on 5% (w/v) polyacrylamide gels in 
45 mM Tris-HCl (pH 8.3), 45 mM boric acid and 1 mM ethylenediaminetetraacetic acid 
(EDTA). The radioactive bands were visualized by autoradiography and quantified in a GS-
800 Densitometer using the Quantity One software (Bio-Rad). 
 
Helicase and ATPase assay. The construction of partial duplex substrates is outlined in Fig. 
S1. Helicase activity was tested by incubating (25°C) the indicated amounts of FaXPD with 
forked 125-mer substrates (5 nM) in a volume of 15 µl containing  20 mM Tris-HCl (pH 7.5), 
5 mM MgCl2, 2 mM DTT and 3 mM ATP (30). The reactions were stopped by the addition 
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of 5 μl loading buffer containing 20% (v/v) glycerol, 0.2 M EDTA, 2% (w/v) sodium dodecyl 
sulfate, 0.25% (w/v) xylene cyanol, 0.25% (w/v) bromphenol blue, 2 mg/ml proteinase K and 
250 nM of unlabeled 125-mers. The products were separated on native 5% (w/v) 
polyacrylamide gels and quantified as described before. The Pi release was measured using a 
colorimetric kit (Innova Bioscience, Cambridge, UK) following the manufacturer’s 
instructions. 
 
Protection assays. To subject helicase reaction products to restriction digestion, the buffer 
(15 µl) was adjusted by the addition of appropriate stock solutions provided for each 
restriction enzyme by the manufacturer. The incubations with SalI, PstI or HaeIII were 
carried out at 30° for 40 min in a final volume of 20 µl. Digested samples were supplemented 
with 5 µl of loading buffer and resolved on native 5-12% (w/v) polyacrylamide gels. 
Alternatively, the reactions were adjusted to 50 mM Tris-HCl, pH 7.5, and 5 mM EDTA in a 
final volume of 20 µl. This mixture was incubated for 30 min at 30°C with 0.015 U of T4 
denV and the reaction was stopped by the addition of 5 µl of 20 mM Tris-HCl, pH 8.0, 0.8 M 
NaCl and 80% (v/v) formamide. After heating to 95°C for 10 min, the samples were chilled 
in an ice-cold water bath and resolved on denaturing 6% (w/v) polyacrylamide gels. 
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Figure Legends 
 
Fig. 1. Interaction of human XPD with damaged sites in living cells. (A) Representative foci 
of UV damage in CHO cells detected by immunochemistry against CPDs 30 min after UV 
irradiation. The accumulation of XPD proteins (wild-type and K48R mutant) is visualized by 
measuring the fluorescence intensity in cells transfected with the respective GFP constructs. 
(B) Comparison between total fluorescence, reflecting the overall expression of XPD fusions, 
and local fluorescence intensity in UV foci (N=30; ± s.e.m.). See SI Text for quantification 
methods. (C) Dissociation of XPD-GFP proteins from UV foci determined by FRAP-LD 
(N=13; ± s.e.m.). See SI Text for a detailed description of data acquisition and analysis. 
 
Fig. 2. Immobilization of the XPD enzyme. (A) Electrophoretic analysis and Coomassie 
staining of FaXPD protein. (B) Oligonucleotide used for competition assays. The CPD is 
indicated by a triangle and the 32P label by an asterisk. (C) Competition in the presence of 3 
mM ATP showing the dissociation of FaXPD from undamaged oligomers (lanes 3-8) and the 
stability of radiolabeled complexes containing a single CPD (lanes 10-15). Competitor DNA 
(undamaged 51-mer) was added in a 50-fold excess. Lane 1: incubation without protein. 
Lanes 2 & 9: control incubations (60 nM FaXPD and 5 nM radiolabeled oligonucleotides) 
without competitor DNA. F, free probes; B, protein-bound fraction. (D) ATP-dependent 
dissociation of FaXPD from undamaged oligonucleotides. Lanes 4 & 8: competition assays 
with non-hydrolyzable ATPγS. (E) Quantification of competition assays. FaXPD (60 nM) 
was incubated (15 min) with radiolabeled 51-mers (5 nM). A 50-fold molar excess of 
unlabeled 51-mers was then added in the presence of 3 mM ATP and, after varying 
competition periods, the samples were analyzed in mobility shift gels. The fraction of 
protein-bound DNA is represented as the percentage of total radioactivity (N=3; ± s.d.). 
 
Fig. 3. Differential impact on XPD enzyme activity. (A) Schematic view of fork substrates. 
The CPD is located either in the 5’–3’ translocated or the 3’–5’ displaced strand. (B) Typical 
autoradiographs showing the inhibition of XPD helicase by a single CPD either in the 
translocated (bottom) or displaced strand (middle panel) of forked substrates (5 nM). (C) 
Dose dependence of helicase activity. The indicated concentrations of FaXPD were incubated 
(15 min) with forked DNA substrate (5 nM). The CPD is located either in the translocated or 
the displaced strand. Oligonucleotide displacement is expressed as the percentage of total 
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radioactivity in each reaction (N=3; ± s.d.). (D) Time course experiments. FaXPD (60 nM) 
was incubated with forked substrates (5 nM) for the indicated time periods (N=3; ± s.d.). (E) 
Dose-dependent stimulation of ATPase activity. The indicated concentrations of FaXPD were 
incubated with forked DNA (5 nM) in helicase reaction buffer containing 3 mM ATP (N=3; 
± s.d.). (F) Time course of Pi release upon incubation of FaXPD protein (60 nM) with forked 
DNA substrates (5 nM) (N=3; ± s.d.). 
 
Fig. 4. Protection assays showing that FaXPD forms a lesion demarcation complex. (A) 
Position of the HaeIII, SalI and PstI recognition sequences in 125-mer forked substrates. (B) 
Protection from SalI cleavage. FaXPD (60 nM) was preincubated (15 min) with partial 
duplexes (5 nM) and ATP (3 mM), followed by treatment with SalI. The SalI site is occluded 
by the XPD helicase when the substrate contains a CPD in the 5’–3’ strand (left) but not if 
the CPD is situated in the 3’–5’ strand (right). Lanes 6-9 & 15-18: control reactions with 
incomplete helicase mixtures. The arrows indicate the position of the displaced strand. (C) 
Glycosylase protection assay with single-stranded DNA (left) and forked substrates (right). 
Helicase reaction products were probed by incubation with T4 denV and resolved on 
denaturing polyacrylamide gels. Lanes 4-7 & 12-15: control incubations with incomplete 
helicase mixtures. 




